Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
75N94018F00005
IGF::OT::IGF CORE FUNCTION ACTIVITIES TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT, AND FUTURE OF THE CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE SITES) ACTIVITIES.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541712 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | HHSN275201300010I |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $516.7K |
| Current contract value | $516.7K |
| Potential contract value / ceiling | $516.7K |
| Start date | Sep 25, 2018 |
| Current end date | Jul 14, 2026 |
| Potential end date | Jul 14, 2026 |
| Latest award activity | Feb 4, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 4, 2026 | P00005 | $4.7K | NICHD: R&D: PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE |
| Mar 12, 2025 | P00004 | $0 | EOI::DEFEND THE SPEND::EOI TERMINATION FOR CONVENIENCE AGREEMENT |
| Jan 16, 2024 | P00003 | $77.3K | PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION CLINICAL TRIAL |
| Sep 28, 2023 | P00002 | $21.9K | PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION CLINICAL TRIAL |
| Sep 28, 2021 | P00001 | $111.2K | PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION CLINICAL TRIAL |
| Sep 25, 2018 | 0 | $301.7K | IGF::OT::IGF CORE FUNCTION ACTIVITIES TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT, AND FUTURE OF THE CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE SITES) ACTIVITIES. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.